Treace Medical Concepts Inc (TMCI) — Cash Flow Reinvestment Rate
Latest as of March 2026:
1.08x
Treace Medical Concepts Inc (TMCI) has a Cash Flow Reinvestment Rate of 1.08x as of March 2026, reinvesting $7.82 Million (capex $3.06 Million plus investments $-4.75 Million) from operating cash flow of $7.23 Million. Check Treace Medical Concepts Inc (TMCI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
1.08x
(Capex + Investments) / Operating CF
Total Reinvested
$7.82 Million
Capex + Investments
Operating Cash Flow
$7.23 Million
USD
Capital Expenditures
$3.06 Million
USD
Annual Cash Flow Reinvestment Rate for Treace Medical Concepts Inc (None–None)
Year-by-year capital reinvestment analysis for Treace Medical Concepts Inc. For live market cap and broader valuation context, see TMCI market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow